Midi Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: menopause-focused care with GLP-1 as a metabolic adjunct
Midi Health scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
Price checked on Midi Health's site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Included
Lab work
Not stated
Coaching
Not stated
Vetted by our editors
PartnerMidi Health is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. GLP-1 prescribing is offered as a clinician-discretionary metabolic-health adjunct within the menopause care framework, not as a standalone weight-loss product. It accepts commercial insurance; Medicare is out of network (self-pay only), and Medicaid and Medi-Cal are not accepted.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Midi Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $166/4 wks (billed per 4 weeks)
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Midi Health
Each dimension is scored algorithmically from Midi Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.9/10Midi Health's headline is $166 every 4 weeks. Compare it with other programs on the same plan basis.
Effectiveness25%
7.7/10Midi Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.7/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.1/10Midi Health treats patients in all 50 states. Insurance pathways are offered for eligible patients.
Support10%
5.4/10Midi Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Midi Health review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers and 2 separate fees
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $164–$210 per 4 weeks across 4 dose/plan tiers, plus two $150–$250 per visit fees that exclude the medication (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Midi Health
We walked Midi Health's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Book a virtual visit through the registration portal.
- 2Meet with a clinician to discuss health history and symptoms.
- 3Receive a personalized care plan and prescriptions, including a GLP-1 plan when clinically appropriate.
- Primarily a women's midlife/menopause telehealth service; the 'Personalized GLP-1 Plan' is one of several care options.
- Insurance-based; accepted by major plans and available in all 50 states.
- No upfront self-pay monthly price is displayed on the homepage.
- A virtual visit with a clinician is required to receive a care plan and prescriptions.
GLP-1 medications Midi Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Per-visit self-pay fee, not a monthly medication price; GLP-1 medication is billed separately or through insurance. Compounded medication prices are published in the ladder rows below.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
Sold as a 4-week supply, so a year is 13 refills, not 12. Price rises with dose: $165.90 (0.1-0.5 mg) to $355.00 (2.5 mg). Shipping and supplies included, no membership fee.
Sold as a 4-week supply (13 refills a year). Price rises with dose: $210.00 (1.25-2.5 mg) to $434.00 (13.75-15 mg). Shipping and supplies included.
Sold as a 4-week supply (13 refills a year). Price rises with dose: $164.00 (0.075 mg) to $275.00 (0.8 mg). Shipping and supplies included.
Sold as a 4-week supply (13 refills a year). Price rises with dose: $209.00 (1 mg) to $460.00 (7 mg). Shipping and supplies included.
Ready to get started?
Plans and promotions change often, so check Midi Health's current pricing and active discounts before you decide.
What we like
- Available in all 50 states
- Accepts commercial insurance, unlike cash-pay-only GLP-1 telehealth services
- Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
- Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
- HSA and FSA funds can pay for visits and services
Watch-outs
- Does not accept Medicaid or Medi-Cal; Medicare is out of network, so Medicare patients must self-pay and cannot submit claims
- GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
- Menopause-focused, so not the right fit for men or younger women whose main goal is weight loss
- Medication is priced per 4-week supply, so a year of treatment is 13 refills, not 12
Midi Health is a menopause clinic that happens to prescribe GLP-1s, not a weight-loss shop
Midi Health is not a fast-lane, fill-out-a-form-and-get-a-shot GLP-1 service. Midi is a nationwide menopause and perimenopause telehealth platform, and GLP-1 medication (compounded semaglutide or tirzepatide, or a brand-name drug) shows up here as one tool inside a broader midlife-women's-health plan, usually alongside hormone therapy and other metabolic support. If you're a woman in your 40s or 50s whose weight gain, sleep, mood, and hot flashes all arrived together, that framing works in your favor. If your only goal is to lose weight as quickly and cheaply as possible, Midi is probably the wrong door to knock on.
How the pricing works: visit fees plus a separate medication bill
Most GLP-1 telehealth brands quote you a single all-in monthly number that bundles the drug and the visit. Midi does not work that way, and that catches people off guard. Midi publishes visit fees and a separate price list for its compounded medications. On the self-pay path you pay one fee for the initial visit and a lower fee for each continued-care visit, and the GLP-1 medication is billed separately on top of that. Compounded medication is sold as a 4-week supply, and the price rises with dose: compounded semaglutide injections run $165.90 to $355.00, and compounded tirzepatide injections run $210.00 to $434.00, with shipping and supplies included. Brand-name GLP-1s are sent to your pharmacy of choice, so their cost depends on that pharmacy and your insurance, and Midi publishes no brand-name price.
For context, a typical all-in GLP-1 telehealth plan runs around $179 a month. Midi's split structure (visit fees plus a 4-week medication price) makes a direct comparison harder. MadeMed is simpler to price, listing a single price at every dose on each product page. Your final number depends on whether you go through insurance or self-pay, and on the medication your clinician chooses. Go in expecting a visit fee plus a separate medication bill, not one tidy subscription price.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
Insurance is where Midi stands apart
Unlike the cash-pay-only crowd, Midi accepts commercial insurance. If your plan covers the visit, you pay only your standard copay and deductible for both the initial and follow-up appointments instead of the self-pay fees. For a lot of women that turns an expensive-looking service into a low-copay one, and it's a meaningful differentiator in a market where most GLP-1 startups won't touch insurance at all.
But read the fine print, because Midi is blunt about it: it does not accept Medicaid or Medi-Cal, and Medicare is out of network. The site says plainly that it cannot accept Medicaid or Medi-Cal patients at this time. Medicare beneficiaries can be seen as self-pay patients, but they cannot submit any claims for Midi visits, medications, or related services. If you're on Medicaid or Medi-Cal, Midi isn't an option, and if you're on Medicare, expect to pay the full self-pay rates.
What's prescribed, and how
- Compounded semaglutide and tirzepatide are both on Midi's price list, as injectables and as sublingual options.
- Brand-name GLP-1s can be prescribed and sent to your pharmacy of choice, but Midi publishes no brand-name price.
- The medication is dispensed separately from your visit, billed through your insurance or paid out of pocket, not bundled into the consult fee.
- Prescribing is clinician-discretionary. A GLP-1 is offered when the clinician judges it appropriate inside your menopause and metabolic plan. It is not promised at intake.
That last point matters: you are not guaranteed a prescription when you sign up. Midi's clinicians decide whether a GLP-1 fits your overall midlife-health picture. That's clinically responsible, but if you arrive expecting an automatic yes, you may be disappointed.
Who should choose Midi, and who should walk
Midi is a strong fit for women navigating perimenopause or menopause who want one team handling hormones and metabolic health together, at the stage of life where GLP-1 efficacy and stubborn midlife weight regulation overlap most. The all-50-states coverage means it works regardless of where you live, and the insurance acceptance can make it surprisingly affordable if your plan plays along.
Skip it if you're a man, a younger woman whose sole focus is weight loss, anyone on Medicaid, or a Medicare patient who wants the visits covered. For a weight-loss-first program, PlexusDx's GLP-1 service says it has licensed providers in all 50 states. Skip it too if price transparency is your top priority. The visit-fee-plus-separate-medication model leaves uncertainty about your monthly total until a clinician sets your medication and dose. People who want a single, locked-in, all-in monthly price will find that frustrating here.
Trust, oversight, and what's missing
On the safety side, Midi reads well. There are no FDA warning letters on file for this provider, and the menopause-specialty framing means GLP-1s are layered into a supervised, whole-person care plan rather than handed out in isolation. The trade-off is a disclosure gap. Compounded prices are published, but brand-name costs depend on your pharmacy and insurance, and Midi names no compounding-pharmacy partner. The care model and state coverage are well documented. You can see how we weigh these factors in our scoring methodology.
Bottom line
Midi Health is the right call for midlife women who want menopause care and metabolic support (including a possible GLP-1) from one insurance-friendly, nationwide clinic, and who don't mind that the medication isn't guaranteed and is billed separately from the visits. It's the wrong call for pure weight-loss shoppers, anyone on Medicaid, Medicare patients who want coverage, and anyone who needs to know their exact monthly cost before they commit. Judge Midi as a menopause specialist that prescribes GLP-1s when warranted, not as a budget weight-loss service, and it's a solid, credentialed choice.
The Bottom Line
Midi Health scores highest on state availability and ease of access.
Ready to start with Midi Health?
From $166 every 4 weeks. See current pricing and start your online intake.
Midi Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Midi Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare Midi Health vs…
Midi Health scores7.0/10
Side-by-side pricing, medications and scores. Pick a matchup.
Midi Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Midi Health vs Vytora Health
Vytora Health scores 8.4/10

Midi Health vs CoreAge Rx
CoreAge Rx scores 8.3/10

Midi Health vs Collective
Collective scores 8.3/10

Midi Health vs Found
Found scores 8.3/10
Midi Health vs EverSlim
EverSlim scores 8.3/10
All 45 Midi Health comparisons
- Midi Health vs AgelessRx
- Midi Health vs altRX
- Midi Health vs Belle Health
- Midi Health vs bmiMD
- Midi Health vs Bodybuilding Health+
- Midi Health vs Brightmeds
- Midi Health vs Direct Meds
- Midi Health vs DudeMeds
- Midi Health vs Eden
- Midi Health vs Embody
- Midi Health vs Enhance MD
- Midi Health vs Gala
- Midi Health vs GobyMeds
- Midi Health vs HealthRX
- Midi Health vs HumeCare+
- Midi Health vs Ivim Health
- Midi Health vs Live Vital
- Midi Health vs Lttl
- Midi Health vs Luvo Health
- Midi Health vs MadeMed
- Midi Health vs MangoRx
- Midi Health vs Maximus
- Midi Health vs MEDGm
- Midi Health vs MEDVi
- Midi Health vs NewSelf
- Midi Health vs Oak
- Midi Health vs PlexusDx
- Midi Health vs Ro
- Midi Health vs RxSpan MD
- Midi Health vs Sesame Care
- Midi Health vs ShedRx
- Midi Health vs SkinnyRx
- Midi Health vs SnagRx
- Midi Health vs Sprout Health
- Midi Health vs Strut Health
- Midi Health vs TMates
- Midi Health vs TrimRx
- Midi Health vs Wellorithm
- Midi Health vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Midi Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Midi Health's current pricing
Plans from $166 every 4 weeks. Start the online intake to check eligibility and today's price.